FDA 483 OBSERVATION · #48 OF 1,923 MOST-CITED

Storage and Distribution

FDA cited this observation 513 times across 479 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Foods513
BY FISCAL YEAR
FY202646
FY202569
FY202454
FY202352
FY202263
FY202123
FY202036
FY201973
FY201875
FY201719
FY20163

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

21 CFR 117.93 · 117.95

Storage and distribution of food and its ingredients were not conducted under conditions that protect against contamination and deterioration — inadequate protection during holding or transport of finished product and raw materials.

Why FDA writes it — Product can be made safely and then spoiled or contaminated in storage or transit. Because storage and distribution occur after the controlled manufacturing steps, weak controls here undo the earlier ones — so FDA cites holding and distribution conditions as part of the food-safety chain.

HOW TO COMPLY
  • Store and transport food and ingredients under conditions that protect against physical, chemical, and microbial contamination and against deterioration of the food and its container.
  • Control temperature and humidity where product safety or quality depends on them.
  • Protect against pests and cross-contamination during holding and distribution.
  • Manage stock rotation and hold/release status so unsuitable product is not distributed.
WHY FIRMS GET CITED
  • Environmental controls (temperature, pest, cross-contamination) applied in production but not extended to storage and transport.
  • No control over hold/release status in the warehouse, so product moves before it should.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your Professional access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1× the rate of the average FDA-cited firm (7.5% vs 7.8%), across 479 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

You did not store or transport a food under conditions that protect against contamination.

P&M Group, Inc. · North Billerica, Massachusetts · Foods · 2026-09-10

You did not store or transport a food under conditions that protect against contamination and deterioration.

High Point Direct · Denver, Colorado · Foods · 2026-08-06

You did not store or transport a food under conditions that protect against contamination and deterioration.

William George Company, Inc · Lufkin, Texas · Foods · 2026-07-08

You did not store or transport a food under conditions that protect against contamination and deterioration.

Mexpobaja Corporation · Oakland, California · Foods · 2026-07-02

You did not store or transport a food under conditions that protect against contamination and deterioration.

Rojas RM, Inc. · Chula Vista, California · Foods · 2026-07-01

You did not store or transport a food under conditions that protect against contamination.

Dream Wholesale Inc · Warren, Michigan · Foods · 2026-06-23

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →